Home - International Society of Microbiota

12th World Congress on Targeting Microbiota 2025

Welcome to ISM 2026

Prof. Alain Stintzi

It is a great pleasure and honour to welcome you to the International Society of Microbiota 2026.As the new President of ISM, I believe our field is entering an important new phase.

We have learned enormously about the composition of the microbiota and its associations with health and disease. Now we need to go further.

The Strategic Questions Shaping the Future of Microbiota Medicine

ISM 2026

Not another microbiome meeting.

A strategic congress designed around the major unanswered questions transforming microbiota science, medicine, industry, and prevention.

Targeting Microbiota 2026 Key Dates

ISM 2026 Confirmed Speakers

Shaping the Future of Microbiota Medicine: From Mechanisms to PreventionAlain Stintzi, University of Ottawa, Canada | The Presidential Lecture of the International Society of Microbiota

Smoking, Microbiota and Immunity: Solving a 40-Year Clinical ParadoxHiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan

The Next Frontier in GeroMedicine: Programming the Microbiome for Healthy LongevitySoheil Saeedi, University of Zurich, Switzerland

Digital Microbiology and Next-Generation Sequencing: Harnessing Clinical Metagenomics for Precision MedicineAshley Rooney, University of Zurich, Switzerland

Can the Microbiome Become a Standard Component of Precision Oncology?Meriem Messaoudene, University of Montreal, Canada

Early-Life Microbiota: Shaping Immunity, Lifelong Health and Disease RiskMercedes Gomez de Agüero Tamargo, Universität Würzburg, Germany

Beyond the Gut: Microbiota-Derived Bile Acids in Tissue Immunity and InflammationTomasz Wypych, Nencki Institute of Experimental Biology PAS, Poland

Can the Gut Microbiome Predict the Next Cardiovascular Event? Insights from the CORDIOPREV CohortAntonio Camargo, University of Cordoba, Spain

From Population Science To Personalised Nutrition: Microbial Metabolites As The Functional Link Between Diet, The Gut Microbiome And HealthCristina Menni, King's College London, UK & University of Milan, Italy

From Mucosal Inflammation to Malignancy: Deciphering the Microbiome at the Crossroads of IBD and Colorectal CancerMichael Scharl, University of Zurich, Switzerland

Concluding Highlights from ISM Annual Meeting 2025

Concluding Remarks

The 12th World Congress on Targeting Microbiota, organized by the International Society of Microbiota (ISM), was held on November 5–6, 2025, at The Westin Valencia, Spain.

This year’s edition brought together more than 180 participants from 23 countries, uniting top scientists, clinicians, and industry innovators to explore how microbiome science is transforming the future of medicine, nutrition, and biotechnology.

Who attended the Targeting Microbiota 2025 ?

Industries
Olobion (Sponsor)
Microomics (Sponsor)
Microbiota & Host (Sponsor)
ADM
Affidea
Affinity Petcare SA
AINIA
Cantabria Labs
Clasado Limited
Copan Italia SpA
Cultech Limited
dzwiekowe pole sp. z o.o.
EFSA
KOLMAR KOREA
Meiji Seika Pharma Co., Ltd.
Medipredict
NAOS ILS
Naturlifes Group Inc
Nutribiótica SL
Rossekk Fernandez S.L.P
SILAB
SEVENTURE PARTNERS

Istanbul University
Juntendo University Graduate School of Medicine
Kaunas University of Technology
McGill University
Medical School A.U.Th.
Microbiology Laboratory, Medical School A.U.Th.
Memorial University of Newfoundland
National University of Singapore
North Carolina State University
Palacký University Olomouc
Pavol Jozef Safárik University in Kosice (PF UPŠ)
Privolzhsky Research Medical University (PRMU)
RIKEN IMS
Russian Medical Academy of Continuous Professional Education
São Paulo State University
SCK CEN, University of Antwerp
Sidra Medicine
Teagasc Food Research Centre
Technical University of Cartagena
Turku University
Universidad CEU Cardenal Herrera de Valencia
Universidad de Navarra
Universidade da Coruña
Universidade do Algarve
Universitas Sumatera Utara
Universitat de Barcelona